These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 30659372)

  • 1. Preventing Heart Failure by Treating Systolic Hypertension: What Does the SPRINT Add?
    Upadhya B; Stacey RB; Kitzman DW
    Curr Hypertens Rep; 2019 Jan; 21(1):9. PubMed ID: 30659372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of Hypertension: Which Goal for Which Patient?
    Jarraya F
    Adv Exp Med Biol; 2017; 956():117-127. PubMed ID: 27722961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical benefit of systolic blood pressure within the target range among patients with or without diabetes mellitus: a propensity score-matched analysis of two randomized clinical trials.
    Li C; Chen K; Shi G; Shi R; Wu Z; Yuan X; Watson V; Jiang Z; Mai H; Yang T; Wang D; Chen T
    BMC Med; 2022 Jun; 20(1):208. PubMed ID: 35718771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart Failure Primary Prevention: What Does SPRINT Add?: Recent Advances in Hypertension.
    Raby K; Rocco M; Oparil S; Gilbert ON; Upadhya B
    Hypertension; 2021 Jun; 77(6):1804-1814. PubMed ID: 33813850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management plans for populations with normal-to-hypertensive blood pressures: risks and benefits of antihypertensive drug treatment in populations previously defined as having high-normal blood pressure.
    Park S
    Korean J Intern Med; 2019 Jan; 34(1):44-49. PubMed ID: 30612417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Intensive Blood Pressure Treatment on Heart Failure Events in the Systolic Blood Pressure Reduction Intervention Trial.
    Upadhya B; Rocco M; Lewis CE; Oparil S; Lovato LC; Cushman WC; Bates JT; Bello NA; Aurigemma G; Fine LJ; Johnson KC; Rodriguez CJ; Raj DS; Rastogi A; Tamariz L; Wiggers A; Kitzman DW;
    Circ Heart Fail; 2017 Apr; 10(4):. PubMed ID: 28364091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential Deaths Averted and Serious Adverse Events Incurred From Adoption of the SPRINT (Systolic Blood Pressure Intervention Trial) Intensive Blood Pressure Regimen in the United States: Projections From NHANES (National Health and Nutrition Examination Survey).
    Bress AP; Kramer H; Khatib R; Beddhu S; Cheung AK; Hess R; Bansal VK; Cao G; Yee J; Moran AE; Durazo-Arvizu R; Muntner P; Cooper RS
    Circulation; 2017 Apr; 135(17):1617-1628. PubMed ID: 28193605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unanswered Questions Regarding Blood Pressure Management for HF Prevention.
    Ramalho SHR; Shah AM
    Curr Hypertens Rep; 2019 Jan; 21(1):7. PubMed ID: 30659378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
    Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
    Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aggressive systolic blood pressure control in older subjects: benefits and risks.
    Chrysant SG
    Postgrad Med; 2018 Mar; 130(2):159-165. PubMed ID: 29375010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Level of Blood Pressure Control and Cardiovascular Events: SPRINT Criteria Versus the 2014 Hypertension Recommendations.
    Ko MJ; Jo AJ; Park CM; Kim HJ; Kim YJ; Park DW
    J Am Coll Cardiol; 2016 Jun; 67(24):2821-31. PubMed ID: 27311520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal Systolic Blood Pressure Target After SPRINT: Insights from a Network Meta-Analysis of Randomized Trials.
    Bangalore S; Toklu B; Gianos E; Schwartzbard A; Weintraub H; Ogedegbe G; Messerli FH
    Am J Med; 2017 Jun; 130(6):707-719.e8. PubMed ID: 28109971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensive Blood Pressure Lowering in Patients With and Patients Without Type 2 Diabetes: A Pooled Analysis From Two Randomized Trials.
    Brouwer TF; Vehmeijer JT; Kalkman DN; Berger WR; van den Born BH; Peters RJ; Knops RE
    Diabetes Care; 2018 Jun; 41(6):1142-1148. PubMed ID: 29212825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of Hypertension Management Strategies in SPRINT-Eligible US Adults: A Simulation Study.
    Zhang F; Bryant KB; Moran AE; Zhang Y; Cohen JB; Bress AP; Sheppard JP; King JB; Derington CG; Weintraub WS; Kronish IM; Shea S; Bellows BK
    J Am Heart Assoc; 2024 Jan; 13(2):e032370. PubMed ID: 38214272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of the SPRINT Trial on Hypertension Management.
    Ghazi L; Oparil S
    Annu Rev Med; 2018 Jan; 69():81-95. PubMed ID: 29414255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic Review for the 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
    Reboussin DM; Allen NB; Griswold ME; Guallar E; Hong Y; Lackland DT; Miller EPR; Polonsky T; Thompson-Paul AM; Vupputuri S
    Circulation; 2018 Oct; 138(17):e595-e616. PubMed ID: 30354656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Blood pressure: the lower the better? Maybe yes].
    Verdecchia P; Angeli F; Aita A; Bartolini C; Garofoli M; Reboldi G
    G Ital Cardiol (Rome); 2016 May; 17(5):335-8. PubMed ID: 27310905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Personalizing the Intensity of Blood Pressure Control: Modeling the Heterogeneity of Risks and Benefits From SPRINT (Systolic Blood Pressure Intervention Trial).
    Patel KK; Arnold SV; Chan PS; Tang Y; Pokharel Y; Jones PG; Spertus JA
    Circ Cardiovasc Qual Outcomes; 2017 Apr; 10(4):. PubMed ID: 28373269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of baseline systolic blood pressure on the relationship between intensive blood pressure control and cardiovascular outcomes in the Systolic Blood Pressure Intervention Trial (SPRINT).
    Sun X; Guo Y; Nie Z; Cheng J; Zhou H; Zhong X; Zhang S; Du Z; Zhuang X; Liao X
    Clin Res Cardiol; 2019 Mar; 108(3):273-281. PubMed ID: 30167807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Going Beyond the Guidelines in Individualising the Use of Antihypertensive Drugs in Older Patients.
    Scott IA; Hilmer SN; Le Couteur DG
    Drugs Aging; 2019 Aug; 36(8):675-685. PubMed ID: 31175614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.